InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Cavanaugh Sarah, Directeur des Affaires Corporatives. Insider active across 1 company, notably Celldex Therapeutics, Inc.. In total, 4 reports have been recorded. Activity tracked since 1 November 2021. The latest transaction was disclosed on 30 May 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Sarah Cavanaugh is Senior Vice President of Corporate Affairs and Administration at Celldex Therapeutics, Inc. She oversees corporate affairs initiatives and ensures regulatory compliance. Her role is essential for the strategic development of the company.